Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health
Clinical trial NCT05724472 · COMPLETED
Trial details
- NCT number
- NCT05724472
- Sponsor
- International AIDS Vaccine Initiative
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2024-01-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.